Session 9: Immunodeficiency and Infections in Patients with CLL

Co-Chair(s)

• 

  Carsten Niemann, MD, PhD

  Associate Professor, Chief Physician
  Department of Hematology, Copenhagen University Hospital Rigshospitalet, Denmark; Hematology Research Group, Danish Cancer Institute Research Center, Denmark; Department of Clinical Medicine, Copenhagen University
  Copenhagen, Denmark
• 

  Clare Sun, MD

  Associate Research Physician
  Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health
  Bethesda, MD, United States

Presentations:

• 10:15 AM – 10:30 AM EDT

  General Management of CLL patients from a Vaccine and Prophylaxis Standpoint
  

  Speaker: Carolyn J. Owen, MD – University of Calgary
• 10:30 AM – 10:45 AM EDT

  What Can We Learn from COVID About Immune Dysfunction and Risk of Infections in CLL?
  

  Speaker: Yair Herishanu, MD – Tel-Aviv Sourasky Medical Center
• 10:45 AM – 11:00 AM EDT

  CLL Vaccine Responsiveness
  

  Speaker: Chris Pleyer, MD – National Institutes of Health
• 11:00 AM – 11:15 AM EDT

  Panel Discussion With Interactivity and Audience Q&ATheme: "How Infections and Immunity Impact Selection of Therapy"
• 11:15 AM – 11:25 AM EDT

  Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with targeted drugs: pooled analysis of clinical trials from the German CLL Study Group (GCLLSG).
  

  Primary Author; Presenting Author: Elia Boccellato, MD – University Division of Hematology, A. O. U. Città della Salute e della Scienza di Torino, Torino, Italy; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy

  Co-Author: Adam Giza, MSc – Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne and Duesseldorf, German CLL Study Group, Faculty of Medicine and University Hospital Cologne, University of Cologne

  Co-Author: Sandra Robrecht, PhD – Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne

  Co-Author: Paula Cramer, MD – Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne

  Co-Author: Julia von Tresckow, MD – Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne and Duesseldorf, German CLL Study Group, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Clinic for Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen

  Co-Author: Othman Al-Sawaf, MD – Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne

  Co-Author: Moritz Fürstenau, MD – Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne

  Co-Author: Eugen Tausch, MD – Department of Internal Medicine III, Ulm University

  Co-Author: Stephan Stilgenbauer, MD, PhD – Department of Internal Medicine III, Ulm University

  Co-Author: Kirsten Fischer, MD – Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne

  Co-Author: Barbara Eichhorst, MD – Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne

  Co-Author: Candida Vitale, MD, PhD – 1 Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Via Genova 3,10126, Torino, Italy
  2 Department of Molecular Biotechnology and Health Sciences, University of Torino
  

  Co-Author: Marta Coscia, MD, PhD – Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Via Genova 3,10126, Torino, Italy2 Department of Molecular Biotechnology and Health Sciences, University of Torino

  Co-Author: Michael Hallek, MD – Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne

  Co-Author: Petra Langerbeins, MD – Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne
• 11:25 AM – 11:35 AM EDT

  Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia
  

  Primary Author; Presenting Author: Randall S. Davis, MD – Department of Medicine and O’Neal Comprehensive Cancer Center, University of Alabama at Birmingham

  Co-Author: Kai Qin – Department of Medicine, University of Alabama at Birmingham

  Co-Author: Kazuhito Honjo – Department of Medicine, University of Alabama at Birmingham

  Co-Author: Scott Sherrill-Mix – Department of Medicine, University of Pennsylvania

  Co-Author: Weimin Liu – Department of Medicine, University of Pennsylvania

  Co-Author: Regina M. Stoltz – Department of Medicine, University of Pennsylvania

  Co-Author: Allisa K. Oman – Department of Medicine, University of Alabama at Birmingham

  Co-Author: Lucinda A. Hall – Department of Radiology, University of Alabama at Birmingham

  Co-Author: Ran Li – Department of Medicine, University of Alabama at Birmingham

  Co-Author: Sarah Sterrett – Department of Medicine, University of Alabama at Birmingham

  Co-Author: Ellen R. Frederick – Department of Medicine, University of Alabama at Birmingham

  Co-Author: Jeffrey R. Lancaster – Department of Medicine, University of Alabama at Birmingham

  Co-Author: Mayur Narkhede – Department of Medicine and O’Neal Comprehensive Cancer Center, University of Alabama at Birmingham

  Co-Author: Amitkumar Mehta – Department of Medicine and O’Neal Comprehensive Cancer Center, University of Alabama at Birmingham

  Co-Author: Foluso J. Ogunsile – Department of Medicine, University of Alabama at Birmingham

  Co-Author: Rima B. Patel – Department of Medicine, University of Alabama at Birmingham

  Co-Author: Thomas J. Ketas – Department of Microbiology and Immunology, Weill Medical College of Cornell University

  Co-Author: Victor M. Cruz Portillo – Department of Microbiology and Immunology, Weill Medical College of Cornell University

  Co-Author: Benjamin M. Larimer – Department of Radiology and O’Neal Comprehensive Cancer Center, University of Alabama at Birmingham

  Co-Author: Anju Bansal – Department of Medicine, University of Alabama at Birmingham

  Co-Author: Paul A. Goepfert – Department of Medicine and O’Neal Comprehensive Cancer Center, University of Alabama at Birmingham

  Co-Author: Beatrice H. Hahn – Departments of Medicine and Microbiology, University of Pennsylvania, Philadelphia